| 141/237 | US=68 / Biol/Mol Ma Y, Feng Q, Pitha-Rowe I, Kitareewan S, Dmitrovsky E. Gene profiling uncovers retinoid target genes. In: Fisher PB. Cancer genomics and proteomics: methods and protocols. New Jersey: Humana Press, 2007. p. 101-21. (Methods in Molecular Biology, 383) ISBN 978-1-58829-504-0. TERAPIA DO CANCER; QUIMIOPREVENCAO DO CANCER; MICROARRAY; GENE PROFILING; GENES ALVO RETINOIDES; RETINOIDES; RECEPTORES NUCLEARES DE RETINOIDE; RIP140 |
| 142/237 | US=76 / Biol/Mol Sioud M. Main approaches to target discovery and validation. In: ___. Target discovery and validation reviews and protocols: emerging strategies for targets and biomarker discovery. New Jersey: Humana Press, 2007. p. 1-12. (Methods in Molecular Biology) ISBN 978-1-58829-656-3. BIOINFORMATICA; GENOMICA; MICROARRAY; PROTEOMICA; DESCOBERTA ALVO; VALIDACAO DO ALVO; ANIMAIS TRANSGENICOS; ANTIGENIOS TUMORAIS |
| 143/237 | US=76 / Biol/Mol Imoto S, Tamada Y, Savoie CJ, Miyano S. Analysis of gene networks for drug target discovery and validation. In: Sioud M. Target discovery and validation reviews and protocols: emerging strategies for targets and biomarker discovery. New Jersey: Humana Press, 2007. p. 33-56. (Methods in Molecular Biology) ISBN 978-1-58829-656-3. ANALISE DE REDES; GENES-ALVO; DESCOBERTA DE DROGAS. VALIDACAO; ESTATISTICAS BAYES; REDE BAYESIANA; REDE BOOLEAN; ALVO DA DROGA; REDE GENE; DADOS MICROARRAY |
| 144/237 | US=76 / Biol/Mol Beaty RM, Gronborg M, Pollack JR, Maitra A. Target discovery and validation in pancreatic cancer. In: Sioud M. Target discovery and validation reviews and protocols: emerging strategies for targets and biomarker discovery. New Jersey: Humana Press, 2007. p. 57-89. (Methods in Molecular Biology) ISBN 978-1-58829-656-3. CANCER DE PANCREAS. DESCOBERTA; CANCER DE PANCREAS. VALIDACAO; BIOINFORMATICA; MICROARRANJOS DE DNA; CANCER DE PANCREAS; PROTEOMICA; DESCOBERTA ALVO; ANALISE SERIAL DA EXPRESSAO GENICA; SAGE |
| 145/237 | US=76 / Biol/Mol Rosok O, Sioud M. Discovery of differentially expressed genes. In: Sioud M. Target discovery and validation reviews and protocols: emerging strategies for targets and biomarker discovery. New Jersey: Humana Press, 2007. p. 115-29. (Methods in Molecular Biology) ISBN 978-1-58829-656-3. DESCOBERTA DE GENES; MICROARRAY; ANALISE DE DIFERENCA REPRESENTACIONAL; ANALISE SERIAL DA EXPRESSAO GENICA; SAGE; DESCOBERTA ALVO; IDENTIFICACAO DO ALVO |
| 146/237 | US=92 / Biol/Mol Smith DL, Nolden LK, Mills GB, Lu Y. Resistance and sensitization: chemo-and radiosensitization through inhibition of PI3K/Akt signaling. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 313-34. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. FOSFATIDILINOSITOL 3-QUINASE; AKT; SIGNALTRANSDUCTION; TERAPIA ALVO MOLECULAR; QUIMIOSSENSIBILIZACAO; RADIOSSENSIBILIZACAO |
| 147/237 | US=92 / Biol/Mol Deininger M. Established cancer therapies: tyrosine kinase inhibitors. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 477-508. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. TERAPIA-ALVO; BCR-ABL; FLT3; EGFR; TYROSISE INIBITORS QUINASE; IMATINIB; GEFITINIB; ERLOTINIB; CANCER; LEUCEMIA |
| 148/237 | US=92 / Biol/Mol Furman RR, Leonard JP, Decter J, Coleman M. Recent and developing cancer therapies: monoclonal antibodies in lymphomas. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 511-36. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |
| 149/237 | US=95 / Biol/Mol Fang B, Roth JA. Vectors: adenovector-mediated cancer gene therapy. In: Hunt KK, Vorburger AS, Swisher SG. Gene therapy for cancer. New Jersey: Humana Press, 2007. p. 3-22. (Cancer Drug Discovery and Development) ISBN 978-0-470-19756-1. CANCER; TERAPIA GENETICA; VETORES; ADENOVETOR MEDIADA; ADENOVIRUS; VETOR ALVO; APOPTOSE; ENSAIOS CLINICOS |
| 150/237 | US=95 / Biol/Mol Lundstrom K. Vectors: alphavirus vectors for gene therapy applications. In: Hunt KK, Vorburger AS, Swisher SG. Gene therapy for cancer. New Jersey: Humana Press, 2007. p. 109-19. (Cancer Drug Discovery and Development) ISBN 978-0-470-19756-1. CANCER; TERAPIA GENETICA; VETORES; ALFAVIRUS; VACINA; INJECAO INTRATUMORAL; TUMOR ALVO |
| 151/237 | US=95 / Biol/Mol Yamamoto M, Curiel DT. Gene therapy approaches: tumor targeting-retargeted adenovirus. In: Hunt KK, Vorburger AS, Swisher SG. Gene therapy for cancer. New Jersey: Humana Press, 2007. p. 197-212. (Cancer Drug Discovery and Development) ISBN 978-0-470-19756-1. CANCER; TERAPIA GENETICA; TUMOR ADENOVIRUS-ALVO REDIRECIONADA; SELETIVIDADE; INFECTIVIDADE; INFECCAO ADENOVIRAL |
| 152/237 | US=95 / Biol/Mol Tandle AT, Libutti SK. Gene therapy approaches: gene therapy targeted at angiogenesis and lymphangiogenesis for cancer treatment. In: Hunt KK, Vorburger AS, Swisher SG. Gene therapy for cancer. New Jersey: Humana Press, 2007. p. 301-30. (Cancer Drug Discovery and Development) ISBN 978-0-470-19756-1. CANCER; TERAPIA GENICA; ANGIOGENESE; LINFANGIOGENESE; TUMOR ALVO; TERAPIA DO GENE ALVEJADO; INIBIDORES ANTI-ANGIOGENICOS; VEGF; NANOPARTICULAS |
| 153/237 | US=12 / Psco/Psq Rummjanek VM, Piuvezam MR, Mascarenhas SR. Métodos: o sistema neuroimunoendócrino: um ano alvo para intervenções farmacológicas. In: Almeida RN. Psicofarmacologia: fundamentos práticos. São Paulo: Guanabara Koogan, 2006. p. 322-44. ISBN 85-277-111-7. SISTEMA NEUROIMUNOENDOCRINO; NEUROTRANSMISSORES; CITOCINAS; HORMONIOS; CELULAS DO SISTEMA IMUNOLOGICO; LINFO-HEMATOPOESE; LINFOCITOS T; CITOCINAS; SISTEMA NERVOSO CENTRAL |
| 154/237 | US=2 / Mama Mass R. Tissue predictive biomakers: erb-B2 as a therapeutic target. In: Gasparini G, Hayes DF. Biomarkers in breast cancer: molecular diagnostics for predicting and monitoring therapeutic effect. New Jersey: Humana Press, 2006. p. 159-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-227-4. BIOMARCADORES PREDITIVOS; ERB-B2; ALVO TERAPEUTICO; CANCER DE MAMA; HER2; TRASTUZUMABE; ANTICORPOS MONOCLONAIS |
| 155/237 | US=1-B / Farmacologia Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 183-200. ISBN 978-0-071-142280-3. AGONISTAS; ANTAGONISTAS DE RECEPTORES MUSCARINICOS; ACETILCOLINA; RECEPTOR ALVO MUSCARINICO; TESTE DE DEGRADACAO DE ESTERES DE COLINA; ALCALOIDES NATURAIS; ANTAGONISTAS DE RECEPTORES MUSCARINICOS; ANTAGONISTAS DE RECEPTORES MUSCARINICOS TERAPEUTICOS |
| 156/237 | US=37 / Câncer Zänker KS. Advances in oncology-from research to application. In: Beuth J, Moss RW. Complementary oncology: adjunctive methods in the treatment of cancer. New York: Thieme, 2006. p. 271-9. ISBN 978-1-5889-0323-0. CANCER; ONCOLOGIA; MEDICINA COMPLEMENTAR; PESQUISA; QUIMIOTERAPIA EM ALTA DOSE; ESTUDOS DE OTIMIZACAO DO TRATAMENTO; ESTRUTURAS ALVO; INIBICAO DA ANGIOGENESE; TERAPIA GENICA; FITOESTROGENOS; POLIFENOIS; NUTRICAO; CANCER. PREVENCAO |
| 157/237 | US=62 / Biol/Mol Sroka TC, Cress AE, Lam KS. Epithelial cell surface targeting using synthetic D-amino acid peptides. In: Cress AE, Nagle RB. Cell adhesion and cytoskeletal molecules in metastasis. New York: Springer, 2006. p. 179-92. (Cancer Metastasis - Biology and Treatment, 9) ISBN 978-1-4020-5128-9. SUPERFICIE DAS CELULAS EPITELIAIS ALVO; PEPTIDEOS SINTETICOS; CANCER EPITELIAL; AMINOACIDO D; SINALIZACAO |
| 158/237 | US=7 / Ortopedia Mekhail T, Abou-Jawde R, Markman M. Principles of medical management. In: McLain RF. Cancer in the spine: comprehensive care. New Jersey: Humana Press, 2006. p. 93-100. (Current Clinical Oncology) ISBN 978-1-58829-074-3. CANCER DA COLUNA; GESTAO MEDICA; BIOLOGIA DO CANCER; ONCOGENE; QUIMIOTERAPIA; TERAPIA ALVO |
| 159/237 | US=7 / Ortopedia Shah J, Mekhail T. Lung cancer. In: McLain RF. Cancer in the spine: comprehensive care. New Jersey: Humana Press, 2006. p. 141-55. (Current Clinical Oncology) ISBN 978-1-58829-074-3. CANCER DA COLUNA; CANCER DE PULMAO; CANCER DE PULMAO. ETIOLOGIA; CANCER DE PULMAO. FATORES DE RISCO; CANCER DE PULMAO. PATOLOGIA; SINDROMES PARANEOPLASICAS; CANCER DE PULMAO. ESTADIAMENTO; CANCER DE PULMAO. DIAGNOSTICO; METASTASE OSSEA; CANCER DE PULMAO. TERAPIA; TERAPIA ALVO |
| 160/237 | US=8 / Quimioterapia Sparreboom A, Zamboni WC. Topoisomerase I-targeting drugs. In: Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 371-413. ISBN 978-0-7817-5628-6. TOPOISOMERASE I; DROGAS-ALVO; CAMPTOTECINA; TOPOTECANO; IRINOTECANO |